| Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis M Romano, D Sollazzo, S Trabanelli, M Barone, N Polverelli, M Perricone, ... Oncoimmunology 6 (10), e1345402, 2017 | 44 | 2017 |
| The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis M Barone, L Catani, F Ricci, M Romano, D Forte, G Auteri, D Bartoletti, ... Oncoimmunology 9 (1), 1782575, 2020 | 30 | 2020 |
| Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis. M Barone, F Ricci, D Sollazzo, E Ottaviani, M Romano, G Auteri, ... Wiley, 2019 | 22 | 2019 |
| Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive … D Forte, M Barone, C Morsiani, G Simonetti, F Fabbri, S Bruno, E Bandini, ... Journal of Experimental & Clinical Cancer Research 40, 1-14, 2021 | 16 | 2021 |
| The “Vesicular intelligence” strategy of blood cancers D Forte, M Barone, F Palandri, L Catani Genes 12 (3), 416, 2021 | 12 | 2021 |
| Mobilized peripheral blood versus cord blood: insight into the distinct role of proinflammatory cytokines on survival, clonogenic ability, and migration of CD34+ cells D Forte, D Sollazzo, M Barone, M Allegri, A di Martella Orsi, M Romano, ... Mediators of inflammation 2018 (1), 5974613, 2018 | 9 | 2018 |
| An abnormal host/microbiomes signature of plasma-derived extracellular vesicles is associated to polycythemia vera M Barone, M Barone, F Ricci, G Auteri, G Corradi, F Fabbri, V Papa, ... Frontiers in Oncology 11, 715217, 2021 | 8 | 2021 |
| Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis. Oncoimmunology 6: e1345402 M Romano, D Sollazzo, S Trabanelli, M Barone, N Polverelli, M Perricone, ... | 5 | 2017 |
| The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases I Vigliotta, S Armuzzi, M Barone, V Solli, I Pistis, E Borsi, B Taurisano, ... Frontiers in Oncology 12, 1001048, 2022 | 4 | 2022 |
| Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms D Forte, F Fanelli, M Mezzullo, M Barone, G Corradi, G Auteri, D Bartoletti, ... International Journal of Molecular Sciences 21 (9), 3399, 2020 | 3 | 2020 |
| A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after … G Chirumbolo, M Dicataldo, M Barone, G Storci, S De Matteis, ... Transplantation and Cellular Therapy 29 (5), 302. e1-302. e8, 2023 | 2 | 2023 |
| Crucial factors of the inflammatory microenvironment promote maintenance of the malignant hemopoietic clone of myelofibrosis by stimulating survival and inhibiting … L Catani, L Rossi, D Sollazzo, E Franchini, M Romano, E Zuffa, M Barone, ... Blood 124 (21), 3220, 2014 | 2 | 2014 |
| A Multiparameter Prognostic Risk Score of Chronic GVHD based on CXCL10 and Plasmacytoid DC (pDC) levels in the Peripheral Blood at 3 months after Allogeneic Hematopoietic Stem … G Chirumbolo, M Dicataldo, M Barone, G Storci, S De Matteis, ... Transplantation and Cellular Therapy, S2666-6367 (23) 01101, 2023 | 1 | 2023 |
| Critical Role of Hodgkin Lymphoma Cells-Derived Large and Small Extracellular Vesicles in the Regulation of the Immune-Inflammatory Microenvironment F Maltoni, C Ciardiello, L Nanni, M Barone, G Narimanfar, B Casadei, ... Blood 140 (Supplement 1), 11509-11511, 2022 | 1 | 2022 |
| The “Vesicular Intelligence” Strategy of Blood Cancers. Genes 2021, 12, 416 D Forte, M Barone, F Palandri, L Catani s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Toward the identification of a microrna-based signature of circulating microparticles from triple negative and JAK2 (V617F) mutated patients with myelofibrosis M Barone, C Morsiani, D Sollazzo, D Forte, S Carloni, F Fabbri, G Auteri, ... Haematologica XV Congress of the Italian Society of Experimental Hematology …, 2018 | 1 | 2018 |
| MUTATIONS IN JAK2 AND CALRETICULIN GENES ARE ASSOCIATED WITH SPECIFIC ALTERATIONS OF THE IMMUNE SYSTEM IN MYELOFIBROSIS M Romano, D Sollazzo, S Trabanelli, N Polverelli, M Barone, M Perricone, ... Haematologica 101, S28-S29, 2016 | 1 | 2016 |
| Iron-Related Laboratory Profile May Predict Response and MRD Negativity Rate in Acute Myeloid Leukemia Patients F Zingarelli, G Cristiano, C Sartor, L Zannoni, J Nanni, M Barone, ... Blood 142, 6052, 2023 | | 2023 |
| MAINTENANCE OF SUPPRESSIVE POTENTIAL IN CRYOPRESERVED GMP-PURIFIED DONOR T REGULATORY (TREG) CELLS FOR INFUSION IN PATIENTS WITH STEROIDEREFRACTORY CHRONIC GVHD M Barone, G Chiurmbolo, E Montelatici, C Lavazza, KM Kwiatkowska, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 117-118, 2023 | | 2023 |
| Parallel Detection of Single-Cells and Extracellular Vesicles from Bone Marrow and Peripheral Blood Reveals Asymmetric Immunometabolic Profile in Acute Myeloid Leukemia D Forte, RJ Argüello, M Barone, S Bruno, G Cristiano, M Cavo, A Curti Blood 140 (Supplement 1), 9158-9159, 2022 | | 2022 |
